...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Merck's profit on Molnupiravir.

Same concerns, as well as potential autoimmune disorders, have been raised by those doctors who believe the COVID-19 vaccines have not been thoroughly tested in the long-term.

My point was the profit margin, which makes one wonder if they will be raising the price on Apabetalone at some point here?

Share
New Message
Please login to post a reply